Introduction
Arterial calcification is a common event in the pathogenesis of arteriosclerosis and is a complicating problem in diabetic and uremic patients (1) . Vascular calcification has been positively correlated with an increased risk of myocardial infarction (2) . Until recently, vascular calcification was considered to be a passive, degenerative, and end-stage process of vascular disease. How-In cases of vascular calcification, the expression of tropoelastin is down-regulated, which most likely decreases elastic fiber formation. However, the function of tropoelastin in vascular calcification remains unknown. We investigated whether tropoelastin affects the induction of vascular calcification. Calcification was induced using inorganic phosphate in cultured bovine aortic smooth muscle cells. The increase in tropoelastin due to the addition of recombinant bovine tropoelastin (ReBTE; 1 or 10 µ µ µ µ µg/ml) or β β β β β-aminopropionitrile (25 µ µ µ µ µg/ml) significantly inhibited calcification at day 6, as assessed by the o-cresolphthalein complexone method. The addition of an elastinderived peptide, VGVAPG peptide (0.1-1000 nM), inhibited calcification at day 6 in a dose-dependent manner. In addition, these responses of β β β β β-aminopropionitrile, ReBTE, and VGVAPG peptide were confirmed using von Kossa staining. To examine whether ReBTE inhibited calcium deposition via the elastin binding protein, lactose and elastin-specific antibody were used. The combination of lactose (20 mM) or this antibody (50 µ µ µ µ µg/ml) with ReBTE (10 µ µ µ µ µg/ml) attenuated the inhibition of calcification. These results suggest that increased tropoelastin inhibits vascular calcification in this model via the interaction between tropoelastin and elastin binding protein. 
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ever, recent studies have suggested that vascular calcification shares several features with mineralization in skeletal tissue, including that the process of vascular calcification may be an active process, as is seen in bone, cartilage, and teeth (3). This active process has been demonstrated by several observations of serum phosphate levels correlated with a tendency toward vascular calcification. In particular, a high serum phosphate level is highly correlated with the extent of vascular calcification in patients with diabetes mellitus and uremic disease (4, 5) . Recently, an in vitro vascular calcification model was developed for analyzing the cellular mechanisms of calcification (6, 7) . In this calcification model, the addition of inorganic phosphate or β-glycerophosphate is used to induce calcium deposition. Employing this system, we previously reported that elastic fiber components were down-regulated by treatment of vascular calcification in cultured bovine aortic smooth muscle cells (8) . Calcification of vascular tissue is a common finding in arteriosclerosis, diabetes, renal failure, aging aortic stenosis, and prosthetic valve replacements. Moreover, vascular calcification is known to cause decreased elasticity, which is partially responsible for disorders related to elastic fibers (9) .
The extracellular matrix regulates many physiological and pathological processes (10) (11) (12) (13) . In the physiological process of bone development, specific extracellular components are produced to create a unique environment that is permissive for the deposition of calcium and phosphate ions as hydroxyapatite minerals (14) (15) (16) (17) . Similarly, in the pathological condition of atherosclerosis, the characteristic extracellular matrix change accompanies the development of atherosclerotic lesions (18) (19) (20) . Elastin is a major component of the extracellular matrix and is secreted from the cells as a soluble monomer, referred to as tropoelastin. This elastin is responsible for the characteristic elastic properties of many tissues, including skin, lung, ligament, and large vascular vessels. Tropoelastin interacts with fibrillin, or microfibril-associated glycoprotein (MAGP), which is the major constituent of microfibrils (21) , and it becomes oriented into the proper alignment for cross-linking by lysyl oxidase. We have reported that potent stimulators of atherosclerosis, such as angiotensine II (22) or endothelin-1 (23), inhibit elastin synthesis, and potent inhibitors of atherosclerosis, such as nitric oxide (24) , minoxidil (25) or heparin (26) , stimulate elastin synthesis. These observations led us to hypothesize that elastin may regulate the development of vascular calcification.
Previous reports have demonstrated calcium deposition along elastic fibers in vascular calcification (27) , and it has been shown that one property of elastin is calcium binding activity (28) (29) (30) (31) . We have already reported that calcium deposition can be clearly observed in autoclaving-resistant elastin fractions using an in vivo calcified model (32, 33) . Reports in this field of study have indicated that a relationship between elastin metabolism and calcification might indeed exist, although there is little agreement regarding the specifics of that relationship. We have also reported that desmosine, a cross-linking amino acid formed in the production of functional elastin from tropoelastin, is down-regulated in the calcified human aorta (34) , suggesting that elastin is qualitatively altered in cases of vascular calcification. However, the direct relationship between the precursor tropoelastin and vascular calcification remains unknown.
In this report, we investigated whether tropoelastin is able to modulate calcium deposition in an in vitro calcification model.
Materials and Methods

Materials
Dulbecco's modified Eagle's Medium (DMEM), fetal bovine serum (FBS), penicillin/streptomycin, L-glutamine, non-essential amino acids, and sodium pyruvate were obtained from Gibco (Rockville, MD, USA). β-Aminopropionitrile fumarate (BAPN) was purchased from Tokyo Kasei (Tokyo, Japan). A mouse anti-elastin antibody, BA4, was obtained from Sigma (St. Louis, MO, USA).
Cell culture and induction of in vitro calcification
Bovine aortic smooth muscle cells (BASMCs) were purchased from Coriell Cell Repositories (No. AG08504) (8) . BASMCs were cultured in DMEM supplemented with 10% FBS, 0.1 mM non-essential amino acid, 2 mM Lglutamine, 100 unit/ml penicillin, and 100 µg/ml streptomycin and were grown to confluent density. In vitro calcification was induced as described previously (6), with slight modification. Briefly, confluent cells were incubated in DMEM containing 4.5 g/l glucose supplemented with 10% FBS and 3 mM sodium phosphate, monobasic (Pi). In several studies, BASMCs were cultured in medium containing BAPN (25 µg/ml), recombinant bovine tropoelastin (1 or 10 µg/ml), lactose (20 mM), or BA4 (50 µg/ml) in the addition of 3 mM Pi. The initial day of culture in Pi-containing media was defined as day 0. The medium was changed every 2 days. For all of the experiments, cells between 3 and 8 passages were used.
Calcification assay and von Kossa staining
The extent of calcium deposition was measured by the o-cresolphthalein complexone method as previously described (35) . The cells were washed three times with tris-buffered saline (TBS) and were treated in 0.6 N HCl for 24 h. The calcium concentration in the HCl supernatant was determined by a Calcium C-test Wako (Wako Pure Chemical Industries, Osaka, Japan). Each cell layer was washed with TBS and solubilized with 0.1 N NaOH containing 0.1% sodium dodecyl sulfate (SDS). The protein concentration in solubilized cells was measured with a BCA protein assay kit (Pierce, Rockford, IL, USA). The calcium content of each cell layer was normalized by the protein content. Calcification was assessed by von Kossa staining. Cells were fixed with 3.5% formaldehyde solution, and then were treated with 5% silver nitrate solution for 30 min under ultraviolet irradiation in order to detect the hydroxyapatite deposition.
Preparation of recombinant bovine tropoelastin
cDNA of a natural splice variant of bovine tropoelastin lacking exon 13 and 14 (ReBTE) was inserted into a pTrcHis Escherichia coli expression vector (Invitrogen, Carlsbad, CA). The ReBTE was purified from bacterial cells according to the manufacturer's instructions (QIAexpression kit, Qiagen KK, Tokyo, Japan). Log-phase cells growing in 500 mL of Luria broth at 37°C were induced to produce protein with 1 mM isopropyl β-Dthiogalactopyranoside. Five hours post-induction, the cultures were pelleted, lysed with 8 M urea, pH 8.0, and centrifuged at 12,000 × g for 20 min. The recombinant protein with the 6 × His tag was separated from other bacterial proteins in the crude lysate by binding to a Ni 2+ resin column (Ni-NTA agarose, Qiagen KK, Tokyo, Japan) and washing out unbound contaminating proteins, followed by elution with a low-pH, 8 M urea wash. The recombinant protein was then dialyzed in 12,000-14,000-molecular weight cut-off dialysis tubing (Spectrum Medical, Laguna Hills, CA, USA) against a 0.25 M acetic acid solution, and lyophilized. The purified ReBTE was analyzed by SDS-PAGE and Western blot analysis.
Statistics
Data were analyzed for statistical significance by Student's t-test in the experiments using BAPN and microcon and by ANOVA with post-hoc Dunnett's analysis in the experiments using only inorganic phosphate, ReBTE, and VGVAPG peptide. Post-hoc Fisher's PLSD was employed in the experiments using lactose and antibody. These analyses were performed with the assistance of StatView version 5.0.
Results
Calcium deposition in a calcification model
It has been reported that Pi induced in vitro calcification in human aortic smooth muscle cells (6) . To confirm that Pi can induce calcium deposition in cultured BASMCs, we treated a Pi-containing medium and measured calcium deposition for 3 and 6 days. The addition of Pi (1-3 mM) significantly increased the calcium contents in the cell layer in a dose-dependent and time-dependent manner, whereas vehicle alone had no effect (Fig. 1 ). The calcium/protein level in the presence of 3 mM Pi at 6 days was 246.5 ± 38.4 (mg/g). These results suggest that the addition of Pi can cause in vitro calcification in cultured BASMCs.
Tropoelastin inhibited calcium deposition in a calcification model
BAPN is an inhibitor for lysyl oxidase that cross-links between lysine residues in tropoelastin. The addition of BAPN to a cultured medium showed that the concentration of soluble tropoelastin increases in cultured medium by inhibiting the maturation of elastin (36) . To examine the effects of increased tropoelastin induced by BAPN treatment on vascular calcification in cultured BASMCs, we treated the cultures with BAPN or with vehicle alone. As shown in Fig. 2 , the addition of BAPN (25 µg/ml) significantly inhibited calcium deposition in Pi-induced calcification at 6 days. The calcium contents were reduced by 62.5% by the addition of 25 µg/ml of BAPN. These results show the possibility that increased endogenous tropoelastin in cultured medium suppresses vascular calcification. Fig. 1 . Calcium deposition on Pi-induced calcification in bovine aortic smooth muscle cells (BASMCs). BASMCs were cultured for 3 or 6 days with the addition of the indicated concentration of sodium phosphate (Pi; 1-3 mM). The calcium contents were measured by the o-cresolphthalein complexone method, normalized by the protein content of the cell layer, and are presented as mean ± SE (n = 4). The differences compared with the control (Pi = 0 mM) for each day were significant (*: p < 0.05, Dunnett's test). Fig. 2 . Effect of β-aminopropionitrile (BAPN) on Pi-induced calcification in BASMCs. BASMCs were cultured for 6 days in 10% FBS-DMEM containing Pi (3 mM) in the presence or absence of BAPN (25 µg/ml). The calcium contents were measured by the o-cresolphthalein complexone method, normalized by the protein content of the cell layer. The data (mean ± SE; n = 4) are presented as the percentage of the control (BAP-N = 0 µg/ml; only Pi treatment). The difference as compared with the control (BAPN = 0 µg/ml; only Pi treatment), was significant (**: p < 0.01, Student's t-test).
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Next, we examined the effects of exogenous tropoelastin on Pi-induced calcification in cultured BASMCs. As shown in Fig. 3 , tropoelastin at a concentration of 1 or 10 µg/ml inhibited calcification, as assessed at 6 days, in a dose-dependent manner. In contrast, vehicle (phosphate buffered saline) alone had no effect. The calcium level was reduced by 70.3% at a concentration of 1 µg/ ml of ReBTE and by 84.2% at a concentration of 10 µg/ ml of ReBTE. These results suggest the possibility that increased tropoelastin suppresses vascular calcification.
In cases of vascular calcification as well as those of bone ossification, calcium ions deposit with phosphate ions as calcium phosphate, especially in hydroxyapatite crystals. To confirm calcium phosphate deposition, we performed von Kossa staining using silver nitrate. The addition of sodium phosphate (3 mM) induced the deposition of black-stained particles (Fig. 4A) . The sodium phosphate-induced particle deposition was partially suppressed by co-treatment with BAPN (Fig. 4B) , and entirely suppressed by ReBTE (Fig. 4C) . In the absence of sodium phosphate, no deposits were found during the culture period (data not shown).
The suppression of calcium deposition in the calcification model occurs via elastin-binding protein (EBP) on the cell surface
The tropoelastin gene has 36 exons in the bovine form, and exon 24 of bovine tropoelastin has repeating sequences of VGVAPG that bind EBP on the cell surface, thereby affecting various cell activities. We investigated whether VGVAPG peptide inhibits calcium deposition in the calcification model. As shown in Fig. 5 , the addition of VGVAPG peptide inhibited calcification at 6 days in a dose-dependent manner. In particular, the calcium levels in the presence of 100 and 1,000 nM of VGVAPG peptide were 27.2 ± 6.4% and 13.4 ± 1.7%, respectively, 3 . Effect of recombinant bovine tropoelastin (ReBTE) on Pi-induced calcification in BASMCs. BASMCs were cultured for 6 days in 10% FBS-DMEM containing Pi (3 mM) in the presence or absence of ReBTE (1 or 10 µg/ml). The calcium contents were measured by the o-cresolphthalein complexone method, normalized by the protein content of the cell layer. The data (mean ± SE; n = 4) are presented as the percentage of the control (ReBTE = 0 µg/ml; only Pi treatment). The difference, as compared with the control (ReBTE = 0 µg/ml; only Pi treatment), was significant (*: p < 0.05, Dunnett's test).
of those seen without this peptide. Moreover, the effect of VGVAPG peptide in this calcification model was confirmed using von Kossa staining (Fig. 4D) . Few blackstained particles were detected by VGVAPG peptide exposure. These results suggest that the VGVAPG sequences are partially responsible for the inhibitory effects of ReBTE.
To test the possibility that the interaction between the VGVAPG sequence and the elastin-receptor is responsible for these inhibitory effects, we applied lactose and mouse anti-elastin antibody (BA4) to BASMC cultures. Lactose is a carbohydrate known to decrease the affinity of the elastin receptor for elastin (37) , and BA4 is specific for an epitope composed of the hexamer VGVAPG, and it suppresses the binding of tropoelastin to the elastin receptor (38) . As shown in Fig. 6 , the treatment of ReBTE (10 µg/ml) decreased the calcium levels in the cell layer. The addition of 20 mM lactose and 50 µg/ml BA4 with ReBTE suppressed the inhibitory effects of ReBTE (Pi versus Pi + ReBTE versus Pi + ReBTE + lactose versus Pi + ReBTE + BA4: 100% versus 38.7% versus 84.2% versus 74.3%, respectively). These results suggest that lactose and BA4 suppress the inhibitory effects of tropoelastin on Pi-induced calcification and that the interactions between VGVAPG and the elastin receptor contribute to the inhibition of Pi-induced calcification.
Discussion
The calcification of vascular tissue is a common finding in patients with atherosclerosis, diabetes, renal failure, aging aortic stenosis, and prosthetic valve replacements. In the present study, we investigated whether tropoelastin is able to inhibit calcification in cultured BSMACs. Since it is known that tropoelastin does not undergo posttranslational modifications, including glycosylation, we prepared ReBTE using a bacterial recombinant protein expression system. We demonstrated that calcium deposition was inhibited by the addition of ReBTE or VGVAPG to the culture medium in this Pi-induced calcification model. The calcium deposition was also inhibited by treatment with BAPN, which is considered to increase tropoelastin contents by inhibiting cross-linking between tropoelastin molecules in this Pi-induced calcification model. These results strongly suggest the possibility that tropoelastin inhibits the development of vascular calcification.
Interactions between cells and elastin are mediated by a non-integrin cell surface receptor complex consisting of three protein subunits (39) (40) (41) . Two of these subunits (61-and 55-kDa subunits) are cell membrane-associated proteins that immobilize the third, a 67-kDa peripheral subunit referred to as the EBP. The EBP has been isolated from developing bovine lung. This peripheral membrane protein has been shown to be an alternatively spliced form of β-galactosidase consisting of two distinct ligand-binding sites within a single molecule, i.e., a galactose binding site and an elastin binding site. The EBP binds predominantly to the repeating VGVAPG hydrophobic domains in the elastin molecule (38) , and the elastin receptor also interacts with moieties through a separate lectin-like binding domain. However, the binding of β-galactosugar-bearing moieties to the lectin domain of the EBP lead to conformational changes in the 67-kDa protein, so that it loses its affinity for elastin and separates from other subunits. Thus, the EBP can be shed from the cell surface by interactions with galactosugars (galactose, lactose) (37) . Moreover, the inactivation of the elastin receptor by lactose and the block of VGVAPG by elastin-specific antibody attenuated the inhibitory effects induced by ReBTE. These results suggest that tropoelastin suppresses the induction of calcification via the interaction of the EBP with VGVAPG sequences in the elastin molecule. Furthermore, as shown in Fig. 6 , precursor tropoelastin did not have a calcium-binding capacity, although it has been reported that elastin and elastin-derived peptide have a calcium-binding capacity (28, 29) . This difference between tropoelastin and elastin-derived peptide may result in the changes in the quality of elastin fiber and contribute to the development of vascular calcification. Indeed, it has been reported that the polarity of amino acid residues in elastin fiber significantly increases with the development of vascular calcification (42) . We also determined the phosphate contents of the culture conditions, but there was no significant difference between the absence and presence of tropoelastin (data not shown).
Recent studies have suggested that the process of vascular calcification may be an active process, as seen in bone tissue (3) . In addition, it is thought that smooth muscle cell mineralization is associated with the loss of smooth muscle-specific gene expression and with the gain of osteoblast-like properties, including the expression of osteoblast differentiation factor (43) , suggesting that the prevention of differentiation to osteoblast-like cells may lead to the inhibition of vascular calcification. Tropoelastin-deficient mice undergo the proliferation of medial smooth muscle cells in the large vasculature (44) . Tropoelastin possibly contributes to the process and conservation of normal differentiation of vasculature. Also, it is possible that tropoelastin suppresses differentiation to bone-like properties from smooth muscle properties in cases of vascular calcification.
In conclusion, we suggest that the interaction between tropoelastin and 67-kDa elastin binding protein regulates the development of vascular mineralization. Several recent studies have supported this hypothesis. Extracellular matrix components such as osteopontin, fibronectin, type IV collagen, matrix Gla protein, and type I collagen regulate the induction of vascular calcification (45) (46) (47) (48) . Our findings may lead to new therapies aimed at the extracellular matrix component; such treatments would be expected to reduce or prevent ectopic calcification.
This study clarified the effects of pure tropoelastin, but not those of degraded elastin, including α-elastin or κ-elastin, in the development of vascular calcification. High and local expression of tropoelastin possibly enables the inhibition of the advancement of vascular calcification and may prevent decreases in aortic elasticity.
